# CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

> **NCT01013415** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 17 (actual)

## Conditions studied

- HIV-1 Infections

## Interventions

- **DRUG:** HAART
- **BIOLOGICAL:** T cells

## Key facts

- **NCT ID:** NCT01013415
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2005-06
- **Final completion:** 2021-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013415, "CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01013415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*